Young men could be at higher risk of contracting Covid-19 than previously recognized, researchers suggested, citing computer models.

Protecting the most vulnerable, Eli Lilly’s bamlanivimab significantly reduced Covid-19 risk for nursing home residents in a Phase III trial.